CN Patent

CN111744019B — 基于甘露糖的mRNA靶向递送系统及其应用

Assigned to Shenzhen Ruiji Biotechnology Co ltd · Expires 2023-08-04 · 3y expired

What this patent protects

本发明提供了一种基于甘露糖的mRNA靶向递送系统及其应用，所述mRNA可以编码一种或多种目标多肽并包含至少一个甘露糖修饰。本发明技术方案通过对mRNA分子进行甘露糖修饰，从而使得mRNA可以与甘露糖直接高效偶联，在不需要载体的情况下实现mRNA的靶向递送。

USPTO Abstract

本发明提供了一种基于甘露糖的mRNA靶向递送系统及其应用，所述mRNA可以编码一种或多种目标多肽并包含至少一个甘露糖修饰。本发明技术方案通过对mRNA分子进行甘露糖修饰，从而使得mRNA可以与甘露糖直接高效偶联，在不需要载体的情况下实现mRNA的靶向递送。

Drugs covered by this patent

Patent Metadata

Patent number
CN111744019B
Jurisdiction
CN
Classification
—
Expires
2023-08-04
Drug substance claim
No
Drug product claim
No
Assignee
Shenzhen Ruiji Biotechnology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.